| 1AIF | B:1-121; H:1-121 | ANTI-IDIOTYPIC FAB 409.5.3 (IGG2A) FAB FROM MOUSE |
| 1AXT | H:1-113 | IMMUNE VERSUS NATURAL SELECTION: ANTIBODY ALDOLASES WITH THE RATES OF NATURAL ENZYMES |
| 1CBV | H:1-122 | AN AUTOANTIBODY TO SINGLE-STRANDED DNA: COMPARISON OF THE THREE-DIMENSIONAL STRUCTURES OF THE UNLIGANDED FAB AND A DEOXYNUCLEOTIDE-FAB COMPLEX |
| 1CK0 | H:1-106 | ANTI-ANTI-IDIOTYPIC ANTIBODY AGAINST HUMAN ANGIOTENSIN II, UNLIGANDED FORM |
| 1CLO | H:1-113 | ANTI-CARCINOEMBRYONIC ANTIGEN MONOCLONAL ANTIBODY A5B7 |
| 1DLF | H: | HIGH RESOLUTION CRYSTAL STRUCTURE OF THE FV FRAGMENT FROM AN ANTI-DANSYL SWITCH VARIANT ANTIBODY IGG2A(S) CRYSTALLIZED AT PH 5.25 |
| 1FL5 | B:1-113; H:1-113 | THE UNLIGANDED GERMLINE PRECURSOR TO THE SULFIDE OXIDASE CATALYTIC ANTIBODY 28B4. |
| 1FL6 | B:1-113; H:1-113 | THE HAPTEN COMPLEXED GERMLINE PRECURSOR TO SULFIDE OXIDASE CATALYTIC ANTIBODY 28B4 |
| 1FLR | H:1-118 | 4-4-20 FAB FRAGMENT |
| 1IAI | I:1-121 | IDIOTYPE-ANTI-IDIOTYPE FAB COMPLEX |
| 1KEL | H:1-115 | CATALYTIC ANTIBODY 28B4 FAB FRAGMENT COMPLEXED WITH HAPTEN (1-[N-4'-NITROBENZYL-N-4'-CARBOXYBUTYLAMINO] METHYLPHOSPHONIC ACID) |
| 1KEM | H:1-115 | CATALYTIC ANTIBODY 28B4 FAB FRAGMENT |
| 1M71 | B:1-113 | CRYSTAL STRUCTURE OF A MONOCLONAL FAB SPECIFIC FOR SHIGELLA FLEXNERI Y LIPOPOLYSACCHARIDE |
| 1M7D | B:1-113 | CRYSTAL STRUCTURE OF A MONOCLONAL FAB SPECIFIC FOR SHIGELLA FLEXNERI Y LIPOPOLYSACCHARIDE COMPLEXED WITH A TRISACCHARIDE |
| 1M7I | B:1-113 | CRYSTAL STRUCTURE OF A MONOCLONAL FAB SPECIFIC FOR SHIGELLA FLEXNERI Y LIPOPOLYSACCHARIDE COMPLEXED WITH A PENTASACCHARIDE |
| 1MAM | H:1-119 | CRYSTAL STRUCTURE TO 2.45 A RESOLUTION OF A MONOCLONAL FAB SPECIFIC FOR THE BRUCELLA A CELL WALL POLYSACCHARIDE ANTIGEN |
| 1MCP | H:1-121 | PHOSPHOCHOLINE BINDING IMMUNOGLOBULIN FAB MC/PC603. AN X-RAY DIFFRACTION STUDY AT 2.7 ANGSTROMS |
| 1NBV | H:1-122 | AN AUTOANTIBODY TO SINGLE-STRANDED DNA: COMPARISON OF THE THREE-DIMENSIONAL STRUCTURES OF THE UNLIGANDED FAB AND A DEOXYNUCLEOTIDE-FAB COMPLEX |
| 1PZ5 | B:1-113 | STRUCTURAL BASIS OF PEPTIDE-CARBOHYDRATE MIMICRY IN AN ANTIBODY COMBINING SITE |
| 1Q72 | H:1-113 | ANTI-COCAINE ANTIBODY M82G2 COMPLEXED WITH COCAINE |
| 1Q9K | B:1-111 | S25-2 FAB UNLIGANDED 1 |
| 1Q9L | B:1-111; D:1-111 | S25-2 FAB UNLIGANDED 2 |
| 1Q9O | B:1-111; D:1-111 | S45-18 FAB UNLIGANDED |
| 1Q9W | B:1-111; D:1-111 | S45-18 FAB PENTASACCHARIDE BISPHOSPHATE COMPLEX |
| 1QYG | H:1-113 | ANTI-COCAINE ANTIBODY M82G2 COMPLEXED WITH BENZOYLECGONINE |
| 1RFD | H:1-113 | ANTI-COCAINE ANTIBODY M82G2 |
| 1RIU | H:1-113 | ANTI-COCAINE ANTIBODY M82G2 COMPLEXED WITH NORBENZOYLECGONINE |
| 1RIV | H:1-113 | ANTI-COCAINE ANTIBODY M82G2 COMPLEXED WITH META-OXYBENZOYLECGONINE |
| 1SBS | H:1-123 | CRYSTAL STRUCTURE OF AN ANTI-HCG FAB |
| 1SM3 | H:1-113 | CRYSTAL STRUCTURE OF THE TUMOR SPECIFIC ANTIBODY SM3 COMPLEX WITH ITS PEPTIDE EPITOPE |
| 1T66 | D:1-118; H:1-118 | THE STRUCTURE OF FAB WITH INTERMEDIATE AFFINITY FOR FLUORESCEIN. |
| 1V7M | H:1-116; I:1-116 | HUMAN THROMBOPOIETIN FUNCTIONAL DOMAIN COMPLEXED TO NEUTRALIZING ANTIBODY TN1 FAB |
| 1V7N | H:1-116; I:1-116; J:1-116; K:1-116 | HUMAN THROMBOPOIETIN FUNCTIONAL DOMAIN COMPLEXED TO NEUTRALIZING ANTIBODY TN1 FAB |
| 1WC7 | B:1-113; H:1-113 | FAB FRAGMENT OF PLP-DEPENDENT CATALYTIC ANTIBODY 15A9 IN COMPLEX WITH PHOSPHOPYRIDOXYL-L-ALANINE |
| 1WCB | B:1-113; H:1-113 | PLP-DEPENDENT CATALYTIC ANTIBODY 15A9 IN COMPLEX WITH ITS HAPTEN |
| 2BMK | B:1-113; H:1-113 | FAB FRAGMENT OF PLP-DEPENDENT CATALYTIC ANTIBODY 15A9 IN COMPLEX WITH PHOSPHOPYRIDOXYL-D-ALANINE |
| 2CK0 | H:1-106 | ANTI-ANTI-IDIOTYPIC ANTIBODY AGAINST HUMAN ANGIOTENSIN II, COMPLEX WITH A SYNTHETIC CYCLIC PEPTIDE |
| 2DLF | H: | HIGH RESOLUTION CRYSTAL STRUCTURE OF THE FV FRAGMENT FROM AN ANTI-DANSYL SWITCH VARIANT ANTIBODY IGG2A(S) CRYSTALLIZED AT PH 6.75 |
| 2MCP | H:1-121 | REFINED CRYSTAL STRUCTURE OF THE MC/PC603 FAB-PHOSPHOCHOLINE COMPLEX AT 3.1 ANGSTROMS RESOLUTION |
| 2R1W | B:1-111 | CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES |
| 2R1X | B:1-111 | CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES |
| 2R1Y | B:1-111 | CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES |
| 2R23 | B:1-111 | CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES |
| 2R2B | B:1-111 | CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES |
| 2R2E | B:1-111 | CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES |
| 2R2H | B:1-111 | STRUCTURE OF S25-2 IN COMPLEX WITH KO |
| 2UUD | H:1-113; J:1-113 | CRYSTAL STRUCTURE OF THE TEPC15-VK45.1 ANTI-2-PHENYL-5-OXAZOLONE NQ10-1.12 SCFV IN COMPLEX WITH THE HAPTEN |
| 2ZKH | H:1-116 | HUMAN THROMBOPOIETIN NEUTRALIZING ANTIBODY TN1 FAB |
| 3BPC | B:1-111 | CO-CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH 5-DEOXY-4-EPI-2,3-DEHYDRO KDO (4.8) KDO |
| 3CK0 | H:1-106 | ANTI-ANTI-IDIOTYPIC ANTIBODY AGAINST HUMAN ANGIOTENSIN II, COMPLEX WITH HUMAN ANGIOTENSIN II |
| 3FO9 | B:1-113; H:1-113 | CRYSTAL STRUCTURE OF ALDOLASE ANTIBODY 33F12 FAB' IN COMPLEX WITH HAPTEN 1,3-DIKETONE |
| 3SY0 | B:1-111 | S25-2- A(2-8)-A(2-4)KDO TRISACCHARIDE COMPLEX |
| 3T4Y | B:1-111 | S25-2- KDO MONOSACCHARIDE COMPLEX |
| 3T65 | B:1-111 | S25-2- A(2-8)KDO DISACCHARIDE COMPLEX |
| 3T77 | B:1-111 | S25-2- A(2-4)KDO DISACCHARIDE COMPLEX |
| 4FAB | H:1-118 | THREE-DIMENSIONAL STRUCTURE OF A FLUORESCEIN-FAB COMPLEX CRYSTALLIZED IN 2-METHYL-2,4-PENTANEDIOL |
| 4HGW | B:1-112 | CRYSTAL STRUCTURE OF S25-2 IN COMPLEX WITH A 5,6-DEHYDRO-KDO DISACCHARIDE |
)
)